These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 37879664)
1. A qualitative study of chronic pain and opioid use: The impact of restrictive prescribing. Sedney CL; Dekeseredy P; Davis M; Haggerty T J Opioid Manag; 2023; 19(7):95-102. PubMed ID: 37879664 [TBL] [Abstract][Full Text] [Related]
2. Pain Management During West Virginia's Opioid Crisis. Haggerty T; Sedney CL; Dekeseredy P; Nwafor D; Brownstein HH; Caretta MA; Pollini RA J Am Board Fam Med; 2022 Oct; 35(5):940-950. PubMed ID: 36257694 [TBL] [Abstract][Full Text] [Related]
4. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect. Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965 [TBL] [Abstract][Full Text] [Related]
5. "You didn't have a choice, but to be on your train. The train was moving": West Virginia pharmacists' perspectives on opioid dispensing during the evolution of the opioid crisis. Haggerty T; Sedney CL; Dekeseredy P; Capehart KD; Pollini RA J Am Pharm Assoc (2003); 2023; 63(3):863-872. PubMed ID: 36870937 [TBL] [Abstract][Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
7. "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use. Behar E; Bagnulo R; Knight K; Santos GM; Coffin PO PLoS One; 2020; 15(3):e0230408. PubMed ID: 32210442 [TBL] [Abstract][Full Text] [Related]
8. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth]. Noufi P; Khoury E; Ayoub E; Naccache N; Richa S Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797 [TBL] [Abstract][Full Text] [Related]
9. Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study. Sanger N; Bhatt M; Shams I; Shahid H; Luo C; Tam SL; Samaan MC; de Souza R; Thabane L; Samaan Z Pain Physician; 2018 Nov; 21(6):E623-E632. PubMed ID: 30508993 [TBL] [Abstract][Full Text] [Related]
10. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location. Kohan LR; Elmofty D; Pena I; Liao C J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425 [TBL] [Abstract][Full Text] [Related]
11. Post-cesarean delivery outpatient opioid consumption and perception of pain control following implementation of a restrictive opioid prescription protocol. Lakhi N; Tricorico G; Kanninen T; Suddle R; Ponterio J; Moretti M Am J Obstet Gynecol MFM; 2019 Nov; 1(4):100049. PubMed ID: 33345839 [TBL] [Abstract][Full Text] [Related]
13. Patient perspectives of transitioning from prescription opioids to heroin and the role of route of administration. Monico LB; Mitchell SG Subst Abuse Treat Prev Policy; 2018 Jan; 13(1):4. PubMed ID: 29378623 [TBL] [Abstract][Full Text] [Related]
15. "The DEA would come in and destroy you": a qualitative study of fear and unintended consequences among opioid prescribers in WV. Sedney CL; Haggerty T; Dekeseredy P; Nwafor D; Caretta MA; Brownstein HH; Pollini RA Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):19. PubMed ID: 35272687 [TBL] [Abstract][Full Text] [Related]
17. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. Thornton JD; Lyvers E; Scott VGG; Dwibedi N J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027 [TBL] [Abstract][Full Text] [Related]
18. 'They say you can get addicted': Exploring factors that fuel the fear of addiction to prescription opioids among cancer survivors. Chavez MN; Tyson DM; Lake PW; Gutierrez A; Sherry P; Rigg KK; Marshall V; Henderson H; Rajasekhara S; Pabbathi S; Lubrano B Eur J Cancer Care (Engl); 2022 May; 31(3):e13582. PubMed ID: 35354227 [TBL] [Abstract][Full Text] [Related]
19. A qualitative evidence synthesis to explore healthcare professionals' experience of prescribing opioids to adults with chronic non-malignant pain. Toye F; Seers K; Tierney S; Barker KL BMC Fam Pract; 2017 Nov; 18(1):94. PubMed ID: 29178843 [TBL] [Abstract][Full Text] [Related]